Literature DB >> 30328581

Hemolytic-uremic syndrome after Escherichia coli urinary tract infection in humans: systematic review of the literature.

Dejan Lavrek1,2, Sebastiano A G Lava3, Gregorio P Milani4, Giacomo D Simonetti1,2, Mario G Bianchetti5,6, Olivier Giannini7.   

Abstract

BACKGROUND: Intestinal infections caused by a shigatoxin-positive Escherichia coli (mostly of the serogroups O26, O45, O103, O111, O121, O145 and especially O157) are a common cause of hemolytic-uremic syndrome. Hemolytic-uremic syndrome was first linked with an E. coli urinary tract infection 40 years ago.
METHODS: We conducted a systematic review of the literature addressing the association between E. coli urinary tract infection and hemolytic-uremic syndrome.
RESULTS: For the final analysis, we retained 23 original reports published since 1979. Five unselected pediatric case series addressed the possible occurrence of hemolytic-uremic syndrome after an acute symptomatic E. coli urinary tract infection among 266 cases and found the mentioned association in 8 (3.0%) cases. We also found 28 individual cases (17 females and 11 males) of hemolytic-uremic syndrome preceded by an E. coli urinary tract infection: 16 children aged from 2 days to 6.0 years and 12 adults aged from 22 to 75 years. Testing for shigatoxin, performed in 19 cases, was positive in 15 cases. E. coli serotyping was performed in 18 cases: testing for serotype O157, O103 and O145 was positive in one, one and two cases, respectively, while testing for serotype O26, O45, O111 and O121 was always negative.
CONCLUSIONS: Hemolytic-uremic syndrome rarely occurs after an acute E. coli urinary tract infection. It affects both children and adults and is mostly caused by germs that are shigatoxin-positive.

Entities:  

Keywords:  E. coli; E. coli serotyping; Hemolytic-uremic syndrome; Shigatoxin; Urinary tract infection

Mesh:

Year:  2018        PMID: 30328581     DOI: 10.1007/s40620-018-0543-x

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  36 in total

Review 1.  Diarrheogenic Escherichia coli.

Authors:  M Noguera-Obenza; T G Cleary
Journal:  Curr Probl Pediatr       Date:  1999-08

2.  Hemolytic-uremic syndrome after Escherichia coli urinary tract infection.

Authors:  R I Hassink; S S Zeerleder; A C Truttmann; M G Bianchetti
Journal:  Pediatr Infect Dis J       Date:  1997-08       Impact factor: 2.129

3.  Haemolytic-uraemic syndrome.

Authors:  D Reymond; M B Bianchetti; A Burnens; H Lior
Journal:  Lancet       Date:  1994-04-23       Impact factor: 79.321

4.  Toxin-mediated haemolytic uraemic syndrome without diarrhoea.

Authors:  A P Kater; A M Westermann; M R de Groot; A E von dem Borne; E J Kuijper
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

5.  Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection.

Authors:  M C Hogan; J M Gloor; J R Uhl; F R Cockerill; D S Milliner
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

6.  Isolation of verotoxin producing Escherichia coli from diarrhoeal and urinary tract infection patients.

Authors:  R Banerjee; K N Kapoor; S Ghatak
Journal:  J Commun Dis       Date:  1999-09

7.  Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype.

Authors:  L Carreras; R Romero; C Requesens; A J Oliver; M Carrera; M Clavo; J Alsina
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

Review 8.  Update on Streptococcus pneumoniae associated hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Bernard S Kaplan; Lawrence Copelovitch
Journal:  Curr Opin Pediatr       Date:  2013-04       Impact factor: 2.856

9.  Adult nondiarrhea hemolytic uremic syndrome associated with Shiga toxin Escherichia coli O157:H7 bacteremia and urinary tract infection.

Authors:  Carlos Chiurchiu; Anna Firrincieli; Marisa Santostefano; Maurizio Fusaroli; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

Review 10.  Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.

Authors:  Arif Asif; Ali Nayer; Christian S Haas
Journal:  J Nephrol       Date:  2016-11-15       Impact factor: 3.902

View more
  3 in total

Review 1.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

2.  Intimate Attachment of Escherichia coli O157:H7 to Urinary Bladder Epithelium in the Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; Tom W Bargar; Stephen D Kachman; Diane R Baker; David H Francis
Journal:  Microorganisms       Date:  2020-02-15

Review 3.  Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases.

Authors:  Ana Carolina de Mello Santos; Fernanda Fernandes Santos; Rosa Maria Silva; Tânia Aparecida Tardelli Gomes
Journal:  Front Cell Infect Microbiol       Date:  2020-07-15       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.